Supernus Pharmaceuticals gets grant for patent granted for compound of formula ii for CNS disorders

1d ago, source: Pharmaceutical Technology

Discover Supernus Pharmaceuticals Inc's groundbreaking patent for a versatile compound aimed at treating central nervous system disorders. Learn about the innovative formula, derivatives, and ...

Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer

15d ago, source:

Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing ...

US FDA declines to approve Abeona’s skin disorder treatment

3d ago, source: WSAY

Abeona Therapeutics said on Monday the U.S. health regulator had declined to approve its treatment for a rare skin blistering ...

Alzheimer’s disease therapeutics Market Will Increase USD 24.3 Billion By 2033 And Has Guessed Around 18.6% CAGR

7d ago, source: PharmiWeb

According to Market.us, the Global Alzheimer’s Disease Therapeutics Market is projected to reach a value of approximately USD 30.8 Billion by 2033, experiencing substantial growth from its 2023 ...

Aurinia Pharmaceuticals to release Q1 earnings report May 2

Opinion ago, source: The Daily Record (Maryland)

Listen to this article Aurinia Pharmaceuticals Inc. Monday announced that it will release financial and operational results ...

Multiple Sclerosis Drugs Market Forecasted to Reach USD 41 Billion by 2032: Unveiling Growth Prospects

8d ago, source: PharmiWeb

According to a recent report by Market.us, the Global Multiple Sclerosis Drugs Market size is expected to be worth around USD 41 Billion by 2032 from USD 29.3 Billion in 2023, growing at a CAGR of 3.8 ...

Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares

2d ago, source:

Goldman Sachs and Leerink Partners are acting as lead joint book-running managers for the proposed offering. Evercore ISI, Guggenheim Securities and BMO Capital Markets are also acting as joint ...